Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1 - PubMed (original) (raw)
Comparative Study
Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1
Wei-Lin Chien et al. Eur J Neurosci. 2005 Mar.
Abstract
Memory is one of the most fundamental mental processes, and various approaches have been used to understand the mechanisms underlying this process. Nitric oxide (NO), cGMP and protein kinase G (PKG) are involved in the modulation of synaptic plasticity in various brain regions. YC-1, which is a benzylindazole derivative, greatly potentiated the response of soluble guanylate cyclase to NO (up to several hundreds fold). We have previously shown that YC-1 markedly enhances long-term potentiation in hippocampal and amygdala slices via NO-cGMP-PKG-dependent pathway. We here further investigated whether YC-1 promotes learning behaviour in Morris water maze and avoidance tests. It was found that YC-1 shortened the escape latency in the task of water maze, increased and decreased the retention scores in passive and active avoidance task, respectively. Administration of YC-1 30 min after foot-shock stimulation did not significantly affect retention scores in response to passive avoidance test. Administration of scopolamine, a muscarinic antagonist, markedly impaired the memory acquisition. Pretreatment of YC-1 inhibited the scopolamine-induced learning deficit. The enhancement of learning behaviour by YC-1 was antagonized by intracerebroventricular injection of NOS inhibitor L-NAME and PKG inhibitors of KT5823 and Rp-8-Br-PET-cGMPS, indicating that NO-cGMP-PKG pathway is also involved in the learning enhancement action of YC-1. YC-1 is thus a good drug candidate for the improvement of learning and memory.
Similar articles
- Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL, Liang KC, Teng CM, Kuo SC, Lee FY, Fu WM. Chien WL, et al. Mol Pharmacol. 2003 Jun;63(6):1322-8. doi: 10.1124/mol.63.6.1322. Mol Pharmacol. 2003. PMID: 12761342 - Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1.
Chien WL, Liang KC, Fu WM. Chien WL, et al. Eur J Pharmacol. 2008 Aug 20;590(1-3):233-40. doi: 10.1016/j.ejphar.2008.06.040. Epub 2008 Jun 15. Eur J Pharmacol. 2008. PMID: 18590724 - Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
Dismuke WM, Sharif NA, Ellis DZ. Dismuke WM, et al. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3353-9. doi: 10.1167/iovs.08-3127. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234350 - Nitric oxide signaling in brain: potentiating the gain with YC-1.
Bredt DS. Bredt DS. Mol Pharmacol. 2003 Jun;63(6):1206-8. doi: 10.1124/mol.63.6.1206. Mol Pharmacol. 2003. PMID: 12761328 Review. No abstract available. - Salutary properties of YC-1 in the cardiovascular and hematological systems.
Tulis DA. Tulis DA. Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct;2(4):343-59. doi: 10.2174/1568016043356200. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320784 Review.
Cited by
- Protein kinase G regulates dopamine release, ΔFosB expression, and locomotor activity after repeated cocaine administration: involvement of dopamine D2 receptors.
Lee DK, Oh JH, Shim YB, Choe ES. Lee DK, et al. Neurochem Res. 2013 Jul;38(7):1424-33. doi: 10.1007/s11064-013-1040-1. Epub 2013 Apr 13. Neurochem Res. 2013. PMID: 23585124 - Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation.
Sabatini MJ, Ebert P, Lewis DA, Levitt P, Cameron JL, Mirnics K. Sabatini MJ, et al. J Neurosci. 2007 Mar 21;27(12):3295-304. doi: 10.1523/JNEUROSCI.4765-06.2007. J Neurosci. 2007. PMID: 17376990 Free PMC article. - Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
Luo J, Lee SH, VandeVrede L, Qin Z, Piyankarage S, Tavassoli E, Asghodom RT, Ben Aissa M, Fà M, Arancio O, Yue L, Pepperberg DR, Thatcher GR. Luo J, et al. BMC Neurosci. 2015 Oct 19;16:67. doi: 10.1186/s12868-015-0208-9. BMC Neurosci. 2015. PMID: 26480871 Free PMC article. - Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties.
Jiang ZJ, Wang CY, Xie X, Yang JF, Huang JN, Cao ZP, Xiao P, Li CH. Jiang ZJ, et al. Br J Pharmacol. 2015 May;172(10):2479-92. doi: 10.1111/bph.13078. Epub 2015 Mar 26. Br J Pharmacol. 2015. PMID: 25573619 Free PMC article. - Dopamine D4 receptors linked to protein kinase G are required for changes in dopamine release followed by locomotor activity after repeated cocaine administration.
Oh JH, Lee DK, Shim YB, Ryu IS, Seo SY, Kim J, Yang JH, Cho HW, Choe ES. Oh JH, et al. Exp Brain Res. 2015 May;233(5):1511-8. doi: 10.1007/s00221-015-4228-6. Epub 2015 Feb 22. Exp Brain Res. 2015. PMID: 25702161
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources